This inventor holds 1 USPTO granted patent. Top assignee: Principia Biopharma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Damien Sallaberry: Inventor in Pharmaceutical Research.
Introduction
Damien Sallaberry is an inventor associated with Le Plessis-Robinson, France. His listed patent concerns chemical compounds investigated for potential therapeutic use. He is associated with Principia Biopharma Inc.
Latest Patents
Sallaberry is credited with 1 patent: “4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one derivatives and salts thereof.” The disclosure describes variants and derivatives of these compounds, along with their salts, for use as agonists and antagonists. It also addresses compositions, preparation methods, and methods of treatment.
Career Highlights
The available information connects Sallaberry’s inventive work with pharmaceutical research at Principia Biopharma Inc. His listed patent focuses on compounds and their possible applications in treatment.
Collaborations
Catherine Arabeyre and Patricia Moliner are identified as some of Sallaberry’s coworkers. The provided information does not specify their roles in the patent or the extent of their collaboration.
Conclusion
Damien Sallaberry’s listed patent reflects research into imidazopyridinone derivatives and their potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile